| P50 | author | Ahmed Idbaih | Q55459195 |
| P2093 | author name string | François Ducray | |
| P2860 | cites work | Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas | Q36236484 |
| | Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. | Q45918451 |
| | Successful chemotherapy for recurrent malignant oligodendroglioma | Q48090619 |
| | Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas | Q48374829 |
| | Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. | Q48493738 |
| | Mutations in CIC and FUBP1 contribute to human oligodendroglioma | Q28244895 |
| | International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors | Q30426724 |
| | Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. | Q30542081 |
| | Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...] | Q33247166 |
| | Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. | Q34446549 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oligodendroglioma | Q1318384 |
| P304 | page(s) | 7-8 | |
| P577 | publication date | 2012-12-11 | |
| P1433 | published in | Nature Reviews Neurology | Q2079285 |
| P1476 | title | Neuro-oncology: anaplastic oligodendrogliomas-value of early chemotherapy | |
| P478 | volume | 9 | |